| Factor Information | |
|---|---|
| Data ID | 87 |
| Factor | Catheter Ablation |
| Description | Catheter ablation for AT in ACHD patients is a safe and effective method of arrhythmia control. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | Electrophysiological Predictors of Acute Procedural Success and Post-Procedure Atrial Tachycardia Recurrence |
| p Value | <0.05 |
| Conclusion | Catheter ablation for AT in ACHD patients is a safe and effective method of arrhythmia control. The majority of patients achieve multiple arrhythmia-free years, but multiple arrhythmia mechanisms are common, and so are latent recurrences requiring repeat procedures. Elimination of all spontaneous and electrically induced AT may be challenging, but nevertheless appears necessary for durable AT-free survival. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 413 |
| CHD Type | isolated CHD |
| CHD Subtype | ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
| Reference | |
|---|---|
| PMID | 31000097 |
| Year | 2019 |
| Title | Catheter Ablation for Atrial Tachycardia in Adults With Congenital Heart Disease: Electrophysiological Predictors of Acute Procedural Success and Post-Procedure Atrial Tachycardia Recurrence |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | chart and procedure report | |
| Region | Columbia, United States | |
| Method | a retrospective study | |
| Race | North America | |
| Disease History | ATs [Of the AT, 179 (93%) were intra-atrial macro-re-entrant tachycardia, and 12 (7%) had a focal origin.] | |
| Treatment History | Underwent catheter ablation for 182 AT; medians includes amiodarone(22), sodium channel blockers(1), beta-bolckers(78), sotalol(14), calcium-channel blockers(8). | |
| Group | Catheter ablation for AT in ACHD patients(Treatment) | N/A(Control) |
| Number | 140 | N/A |
| Age | 45±1.2 (mean ± SEM) | N/A |
| Gender (Male: Female) | 71:69 | N/A |
| Marker Level | N/A | N/A |
